Stopped by police with a prescription: your rights

Two threads this issue. Your rights when prescribed cannabis meets the law, on the pavement and on the road, and a genuine clash over whether the medicine works, after a big survey and a sceptical trial review landed days apart. We have kept both plain and honest, and we are firmly in your corner.

Medical cannabis has been lawful in the UK since 2018, yet carrying it in public still unsettles many patients. The difficulty is rarely the law. It is proving, on the spot, that your medicine is genuinely prescribed, to an officer who may not know the law allows it.

What this means for you: if your cannabis is prescribed, you are within the law. National police guidance made public in January 2026 tells officers to treat prescribed patients as patients first. The most useful thing to carry is your medicine in its original packaging with the dispensing label readable, since that ties the medicine to you. Keep your prescription or pharmacy documentation with it, and if stopped, explain calmly that it is a prescribed medication.

If your medicine is seized: an officer who cannot verify it may still take it, even when it is lawful. Do not resist. Ask for a written record of the seizure, then follow up through the force’s formal process and seek legal advice, because enforcement is inconsistent and some cases are resolved only after the event.

The bigger picture: in January 2026 the first national guidance for police on prescribed cannabis was made public across England and Wales, on a patients-first, suspects-second basis, telling officers to check with your clinic rather than assume the worst. It does not change the law, and not every officer will know it yet, so the practical task is still proving a prescription quickly. But the gap is awareness, not ill intent, and it is now closing.

Read our full guide: If you are stopped by the police.

Sources: NPCC and APCDLO police guidance, made public January 2026. The general position, not any clinic’s own service.

Plain English: driving on a prescription

The rule. Since 2015, England and Wales have set legal limits for sixteen drugs behind the wheel, including cannabis. Being over the limit is an offence in itself, separate from whether your driving is affected.

The defence that protects patients. The law includes a medical defence. If a medicine was lawfully prescribed and you took it as directed, and your driving is not impaired, you are not breaking the law even if you are over the limit. The limits are set to allow the normal doses most patients are prescribed.

In practice. Take your medicine as your clinician directs, never drive while you feel affected, leave enough time before driving, and carry proof of your prescription. The penalty for the offence is serious, a minimum twelve-month ban, a heavy fine, and a criminal record, so the defence is worth understanding properly.

Official guidance: gov.uk/drug-driving-law ↗. For your own situation, ask your prescriber.

Source: GOV.UK and UK drug-driving regulations. Education only, not legal advice.

The evidence: does it work?

Two very different answers landed this week on whether medical cannabis helps mental health. Both deserve your attention, and neither settles the question.

What patients report. A survey of 6,282 UK patients across four clinics found that, among the 5,128 treated for anxiety, depression or PTSD, 97.6% reported their symptoms improved, 92.3% slept better, and 93.5% functioned better day to day. Striking numbers. The catch: this is voluntary, self-reported data, gathered by the clinics themselves, who stress it is not proof that the medicine works.

What the trials say. Days earlier, a review in The Lancet Psychiatry concluded that routine use of cannabis for mental health is rarely justified on current trial evidence, finding no significant effect for anxiety, depression or PTSD, with some signal for cannabis dependence and tics.

Where experts disagree. Researchers at Drug Science argue the review used the wrong yardstick, because randomised trials suit single molecules, not whole-plant medicine and complex patients, around 90% of whom would not qualify for such a trial. They also note the review included only about 1% of the studies it screened, so a thin result reflects scarce research, not proof of failure.

What this means for you. Hold both honestly. Many patients report real benefit, and the strict trial evidence is thin and contested. Absence of strong trial evidence is not the same as proof that something does not work, and a dramatic survey figure is not proof that it does. If this affects your own treatment, talk it through with a clinician who knows your history.

Sources: The Pharmaceutical Journal ↗ on the Lancet Psychiatry review, and Drug Science ↗ on the critique. A multi-clinic UK patient survey, reported June 2026. Not medical advice.